Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Digna Biotech, S.L. Snapshot 5 Digna Biotech, S.L. Overview 5 Key Information 5 Key Facts 5 Digna Biotech, S.L. - Research and Development Overview 6 Key Therapeutic Areas 6 Digna Biotech, S.L. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Digna Biotech, S.L. - Pipeline Products Glance 13 Digna Biotech, S.L. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Digna Biotech, S.L. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Digna Biotech, S.L. - Drug Profiles 17 Cardiotrophin-1 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 disitertide 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Interferon Alfa-5 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 DB-017 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 DB-02901 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 DB-036 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 DB-039 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 DB-055 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 oncostatin M 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 DB-027 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Digna Biotech, S.L. - Pipeline Analysis 30 Digna Biotech, S.L. - Pipeline Products by Target 30 Digna Biotech, S.L. - Pipeline Products by Route of Administration 31 Digna Biotech, S.L. - Pipeline Products by Molecule Type 32 Digna Biotech, S.L. - Pipeline Products by Mechanism of Action 33 Digna Biotech, S.L. - Recent Pipeline Updates 34 Digna Biotech, S.L. - Dormant Projects 35 Digna Biotech, S.L. - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38

List of Tables Digna Biotech, S.L., Key Information 5 Digna Biotech, S.L., Key Facts 5 Digna Biotech, S.L. - Pipeline by Indication, 2016 7 Digna Biotech, S.L. - Pipeline by Stage of Development, 2016 9 Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016 10 Digna Biotech, S.L. - Partnered Products in Pipeline, 2016 11 Digna Biotech, S.L. - Partnered Products/ Combination Treatment Modalities, 2016 12 Digna Biotech, S.L. - Phase II, 2016 13 Digna Biotech, S.L. - Phase I, 2016 14 Digna Biotech, S.L. - Preclinical, 2016 15 Digna Biotech, S.L. - Discovery, 2016 16 Digna Biotech, S.L. - Pipeline by Target, 2016 30 Digna Biotech, S.L. - Pipeline by Route of Administration, 2016 31 Digna Biotech, S.L. - Pipeline by Molecule Type, 2016 32 Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016 33 Digna Biotech, S.L. - Recent Pipeline Updates, 2016 34 Digna Biotech, S.L. - Dormant Developmental Projects,2016 35 Digna Biotech, S.L., Other Locations 36 Digna Biotech, S.L., Subsidiaries 36 List of Figures Digna Biotech, S.L. - Pipeline by Top 10 Indication, 2016 7 Digna Biotech, S.L. - Pipeline by Stage of Development, 2016 9 Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016 10 Digna Biotech, S.L. - Pipeline by Target, 2016 30 Digna Biotech, S.L. - Pipeline by Route of Administration, 2016 31 Digna Biotech, S.L. - Pipeline by Molecule Type, 2016 32 Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016 33